Hot or Not: Tumor Mutational Burden (TMB) as a Biomarker of Immunotherapy Response in Genitourinary Cancers
Brian Halbert, David J. Einstein
Topics & Concepts
MedicineBiomarkerPembrolizumabNonsynonymous substitutionImmunotherapyGenitourinary systemOncologyComputational biologyCancer researchInternal medicineGeneticsCancerGenomeGeneBiologyCancer Immunotherapy and BiomarkersBladder and Urothelial Cancer TreatmentsCancer Genomics and Diagnostics